The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages.   

Let’s take a look at the rise of cannabis-infused beverages and how you can invest in Innoviom, Inc.—a pioneer in the space—with as little as $2,500 through the MAZAKALI platform to capitalize on these trends.

Cannabis-Infused Beverages

Cannabis beverages are projected to become a $2.8 billion market by 2025, according to Grand View Research, which represents a blistering 17.8% compound annual growth rate. While the industry is highly fragmented at the moment, Molson Coors projects that cannabis drinks will eventually represent one-third of all cannabis sales as the industry matures.

Click here to receive more information on investing in Innoviom

Several large companies have already begun to position themselves in the space:

• Heineken launched Hi-Fi Hops—a CBD and THC-infused beverage with zero calories.
• Molson Coors took a controlling stake in HEXO Inc., a Canadian licensed producer.
• Anheuser-Busch InBev invested $50 million in a joint venture with Tilray Inc.
• Constellation Brands acquired a 38% stake in Canopy Growth Corp. for $4 billion.

Many alcohol conglomerates believe that THC-infused beverages could compete with alcohol in the future and seek to position themselves to diversify risk. However, Millennials appear to be equally interested in CBD-infused functional beverages that incorporate natural substances, like adaptogens, probiotics and vitamins, to improve wellness. 

Innoviom Makes Big Progress

Innoviom was founded by executives from Coca-Cola, Pepsi, RedBull and other leading beverage brands to build on these CBD wellness trends and take them to scale. The company’s Wowie brand is a hemp-infused beverage that contains 20mg of hemp and a mix of adaptogens designed to promote relaxation.

In combination with Tranquini and its new NaturGeeks brands, the company has been consistently doubling its sales each month through Amazon.com and other online platforms. Management expects to be live in the UK on December 1 and rollout its products in the European Union in January of next year amid its international expansion.

Click here to receive more information on investing in Innoviom

With an established supply chain, manufacturing and distribution network already in place, the company is well on its way to expanding its presence throughout the United States. The company’s move to trademark the name in 120 countries and seek regulatory approval in 30+ countries suggests that further international expansion is also in the cards.

How to Invest in Innoviom

Innoviom has recently announced a $3 million capital raise in order to support its growth. While the company has already closed $1.2 million in funding for this round, interested investors still have an opportunity to participate in the remainder of the financing round over the coming weeks.

Accredited investors can participate in a direct private placement with a minimum investment of $30,000 or invest in MAZAKALI’s Special Investment Vehicle with a minimum investment of just $2,500. For more information, sign up for MAZAKALI’s platform and access the terms.

Click here to receive more information on investing in Innoviom

The Bottom Line

Cannabis beverages have already attracted tremendous interest in both the alcohol and wellness industries. With its unique combination of cannabinoid and non-cannabinoid relaxation beverages, Innoviom is well positioned to benefit from an increase in demand for CBD-infused functional beverages.

For more information, visit the company’s website or request more information today!

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

The idea of your dog taking marijuana products can be scary. You don’t know how they might react to the effects. Don’t worry, though, CBD won’t make your dog high because it is not psychoactive.

CBD is one of the cannabinoids found in marijuana. Unlike THC (Tetrahydrocannabinol), which is psychoactive, CBD is known more for its anti-inflammatory and antioxidant properties.

Humans have used cannabis for over a thousand years to treat various illnesses. Now, many pet owners are turning to cannabis products to treat their sick pets as well and finding it very beneficial.

Cannabinoids like CBD are potential treatments for various diseases, including inflammatory bowel disease, chronic pain, lack of appetite, and epilepsy. CBD is also used in the management of cancer, nausea, and vomiting.

Dogs have an endocannabinoid system similar to that of humans. It means that a substance that affects the human endocannabinoid system will affect dogs in the same way.

Many pet owners are turning to CBD oil for dogs. Here is why:

1. It Relieves Stress and Anxiety

Does your dog have separation or noise anxiety? Does it bark a lot and get jittery when you leave? CBD may help.

CBD binds to dogs’ endocannabinoid system and helps in balancing emotions. When you give a dog CBD, the drug is known to intiate neurotransmitters that convey hormones that calm the dog when stressed.

CBD is not only useful for dogs with separation anxiety but also phobia. If your dog can’t be around people, you can try giving it some CBD.

2. Improves Brain Function

When you bond with your dog, you become lifetime friends. Sadly, dogs do not live as long as humans. They have a lifespan of about 13 years. Your dog will start aging rapidly after about eight years. This can be a sad process as its brain starts to waste.

Inflammatory Central Nervous System (CNS) Disease is common in older dogs. When a dog has CNS, it may lose the sense of its environment. Communicating with it will become difficult, and it may lose its way around frequently.

Endocannabinoids play a key role in modulating neurotransmitter activity in the CNS system. This provides evidence that the dysfunction of the cannabinoid system contributes to canine inflammatory CNS diseases.

Placing your aging dog on CBD therapy can help boost its endocannabinoid system. CBD supports mitochondria development and cellular function. CBD is also known to have anti-inflammatory benefits, which improve brain health.

3. CBD Treats Itchiness

You probably have a dog that itches a lot, and no medication seems to work. The cause may be food, fleas, or lice. Some dogs seem to respond better to these allergies than others. The secret is that they have a strong immune system.

CBD offers relief for many allergic reactions in dogs such as dermatitis. The anti-inflammatory properties in CBD can be useful for itchy dogs. CBD can also boosts the dog’s immunity, giving it a better chance to manage allergies.

4. CBD Increases Appetite

Is your dog giving you trouble eating and you can’t find a solution? Dogs need to have a good appetite because that is what makes them healthy.

If the dog is unwell it may have nausea, which may cause a lack of appetite. Without eating, your dog may not have a good chance of fighting off diseases.

CBD can stimulate appetite and help dogs that are struggling to eat. CBD can also help sick dogs relax and get quality sleep, which is helpful for healing.

5. CBD Relieves Pain

Chronic pain is a prevalent condition in dogs. This type of pain is maladaptive as it does not offer any protective function. Pain causes stress in dogs and takes out their joy. If your pet seems dull, it could possibly be suffering from chronic pain.

CBD can be efficient in treating hard to treat pain. It also is known to have anti-inflammatory properties that help reduce inflammation that causes pain. The endocannabinoid receptors that CBD binds to also help modulate pain transmission.

While CBD is not a conventional treatment for dogs, many holistic veterinary practitioners recommend CBD for dogs suffering from joint pain. Joint pain caused by arthritis is common in aging dogs.

CBD can relax the nerves and help soothe the pain resulting from damaged nerves or cartilage. CBD can also be beneficial in alleviating intestinal inflammation.

6. CBD is natural and Non-toxic

If you are worried about CBD toxicity, worry not. Many studies that focus on the toxicity of marijuana look at the psychoactive element THC and not CBD in isolation.

CBD is not psychoactive, and it will not give the euphoric high associated with marijuana. CBD contains therapeutic properties without the psychoactive element.

There is no toxicity associated with CBD. You don’t have to worry about your dog overdosing and getting sick from CBD.

What this all Means

CBD is seen as a revolutionary treatment for many diseases in humans and now the benefits are being extended to dogs. CBD is not only known to offer relief from ailments, but it also can improve the overall health of the dog.

There is limited research on the benefits of CBD to dogs. However, initial studies show promising outcomes with fears of toxicity having been ruled out. Some dog owners and vets are already experimenting with CBD on their sick dogs. While there is still a long way to go, the results show great potential.

The COVID-19 outbreak has severely disrupted the economy and could push the world into the sharpest economic contraction since the Great Depression in the 1930s. While the cannabis industry has been largely spared thus far, companies have been forced to adopt new business models and strategies to succeed in the ‘new normal’.

Innoviom, a nimble beverage and foods start-up that builds on consumer market trends and takes them to scale, is well-positioned to succeed in the current macroeconomic backdrop given its highly experienced management team, it’s unique focus on relaxation beverages and its rapid pivot to sell products through ecommerce channels—including Amazon.com in recent weeks.

CEO Ahmed El Azizi explains what makes Innoviom products unique.

If you’re an accredited investor interested in functional beverages, you can sign up to receive the company’s investor presentation and learn more about its current offerings.

Perfectly-Positioned Beverage Products

Innoviom’s great tasting, low-calorie, adaptogen-containing relaxation beverages are designed to relieve stress, reduce anxiety and enhance mood without causing drowsiness with lavender, lemon balm, chamomile, green tea, and other all-natural ingredients. In addition, Wowie by Tranquini includes 20mg of hemp-derived cannabidiol, or CBD, per can.

These innovative products are uniquely suited to address consumer needs in the current high-stress COVID-19 environment. All of Innoviom’s products allow you to work/study from home with less stress and anxiety from juggling all the responsibilities with little outside help. Reducing stress while being active, helps consumers to be at their best even in the current situation.

With cannabinoid-free and CBD-only versions, consumers across the spectrum can access these products in any market without having to visit a dispensary or worry about the legal status of cannabis in their state.

With an established supply chain, manufacturing and distribution network already in place, the company is well on its way to expanding distribution throughout the United States. The company’s move to trademark the name in 120 countries and seek regulatory approval in 30+ countries suggests that international expansion is in the cards.

Reaching Millions of Customers via Ecommerce Sales

Innoviom recently began selling its Tranquini brand of products, with or without CBD, on Amazon.com and Tranquini.com. With its agile management team, the company was able to pivot to e-commerce and significantly expand upon its existing presence in U.S. retail chains, like Meijer. The company also works with distributors, like KeHE and UNFI.

Relax and be positive with Innoviom’s Tranquini adaptogen-blend beverages.

Take a break and hang loose with Innoviom’s CBD-infused  beverages.

“A cultural shift in consumption also contributes [to the growth in CBD beverages],” says Duane Stanford, Beverage Digest Executive Editor. “Consumers [are] increasingly looking for natural products with health benefits and are reducing their alcohol intake. CBD drinks are positioned as a potential aid for conditions from anxiety to muscle pain.”

The functional beverage market is projected to grow at an 8.66% CAGR to reach $208.13 billion by 2024, according to Research and Markets. Zenith Global believes that CBD beverages will be among the fastest-growing subsets of the functional beverage industry, growing from just $86 million in 2018 to $1.4 billion by 2023.

A Unique Investment Opportunity

Innoviom is led by CEO Ahmed El Azizi, former Global VP of Functional Beverages at PepsiCo. He is joined by Group CFO Christine Morcos, who worked with Pfizer, Gillette and Procter & Gamble and Julia Trofimova, who formerly served at Diageo, Red Bull and other mainstream consumer product companies, 

CEO Ahmed El Azizi discusses management’s experience in the space.

Accredited investors interested in the functional beverage and CBD industries can sign up to receive the company’s investor presentation and details about their offerings.

Company Contact:

Innoviom, Inc.

Ahmed El Azizi

CEO

[email protected]

CFN Media

Frank Lane

President

[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.